NRF2 has been found to be expressed at high levels in urothelial carcinoma of the bladder, and the silencing of NRF2 restricts proliferative and invasive potential and enhances apoptotic capacities of tumor cells29. This evidence concerns the gene NFE2L2 and neoplasm.